Growth Hormone Disorders Completed Phase 1 Trials for Somatropin pegol (DB15112)

Also known as: Growth Hormone Disorder

IndicationStatusPhase
DBCOND0036845 (Growth Hormone Disorders)Completed1
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01034202Dose Study in Healthy Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083 Compared to Norditropin® SimpleXx®Treatment
NCT00722540Dose Study in Healthy Japanese Males Investigating Safety, Pharmacokinetics and Pharmacodynamics of NNC126-0083Treatment